THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS

Transcription

1 THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS PUBLISHED OCTOBER 2016

2 [Question to respondents: Which companies have the best record for supplying high-quality, useful products?] Probably smaller biotechs. Everybody else just imitates, or buys products and companies. National Canada-based patient group specialising in rare diseases (including respiratory conditions) Most information on adverse affects or clinical trials is not open source in India, and patients have very little access to such information. National India-based patient group specialising in chronic disease in general (including respiratory conditions) in 2016, patientview is publishing 20 corporate reputation of pharma reports, analysing the results from the 1,075 patient groups responding to the 2015 survey. specialty reports: cancer I circulatory conditions I diabetes I hiv/aids I hepatitis I neurological conditions I mental health I respiratory conditions I skin conditions I rare diseases (10 reports) country/geographic region reports: europe I eastern europe I germany I global I italy I latin america I nordic I spain I uk I usa (10 reports)

3 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID RESPIRATORY PATIENT GROUPS SAY ABOUT PHARMA IN 2015? Summary of the industry-wide findings (as judged by respiratory patient groups) Page 3 SOME POINTS ABOUT THE RESPIRATORY CORPORATE-REPUTATION RANKINGS Page 6 WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION? Page 7 COMMENTS FROM RESPIRATORY PATIENT GROUPS, 2015 Page 8 METHODOLOGY OF THE PATIENT-GROUP SURVEY Page 11 APPENDIX 1: Data on how respiratory patient groups see the pharmaceutical industry in 2015 (and compared with the results from patient groups across all therapy areas in 2015) Page 12 APPENDIX 2: Rankings of the 15 pharma companies for each of the six indicators of corporate reputation, as perceived by respiratory patient groups in 2015 Page 17 APPENDIX 3: Profile and analysis of each of the 15 pharma companies, as perceived by respiratory patient groups in 2015 Page 26 APPENDIX 4: Profile of the 118 respondent respiratory patient groups Page 43

4 LIST OF TABLES AND CHARTS BASED ON THE VIEWS OF RESPIRATORY PATIENT GROUPS, 2015 Percentage of respiratory patient groups claiming familiarity with the company Page 2 Percentage of respiratory patient groups claiming familiarity with the company, and which also worked with it Page 2 Percentage of patient groups of different therapy areas worldwide stating that the pharma industry had an Excellent or Good corporate reputation in 2015 Percentage of patient groups worldwide (by therapy area) stating that pharma is Excellent or Good at BEING INNOVATIVE Percentage of patient groups worldwide (by therapy area) stating that pharma is Excellent or Good at PROVIDING HIGH-QUALITY PRODUCTS Percentage of patient groups of different therapy areas worldwide in 2015 stating that pharma is Excellent or Good at BEING TRANSPARENT Percentage of patient groups of different therapy areas worldwide in 2015 stating that pharma is Excellent or Good at HAVING INTEGRITY Overall 2015 rankings of companies by patient groups, based on a standardized index the Patient Corporate Reputation Index (PCRI) Page 3 Page 4 Page 4 Page 5 Page 5 Page 6 If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Page 7 How do you think your organisation s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015? Page 13 What do you think has happened to the corporate reputation of the pharma industry over the past five years? Page 14 How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? Pages 15 and 16 Indicator 1: Companies with the most effective patient-centred strategy (rankings of 15 companies, 2015) Page 18 Indicator 2: Companies providing the best high-quality patient information (rankings of 15 companies, 2015) Page 19 Indicator 3: Companies with the best record on patient safety (rankings of 15 companies, 2015) Page 20 Indicator 4: Companies with the most-useful high-quality products (rankings of 15 companies, 2015) Page 21 Indicator 5: Companies with the best record of transparency (rankings of 15 companies, 2015) Page 22 Indicator 6: Companies with the best record on integrity (rankings of 15 companies, 2015) Page 23 Rankings of the 15 pharmaceutical companies in 2015, ALPHABETIC ORDER Page 24 Rankings of the 15 pharmaceutical companies in 2015, HIGHEST TO LOWEST Page 25 Profile of 2015 s 118 respondent patient groups with an interest in respiratory conditions by country Page 44 Geographic remit of 2015 s 118 respondent patient groups with an interest in respiratory conditions Page 44

5 LIST OF TABLES AND CHARTS CONTINUED AbbVie page 28 Amgen page 29 AstraZeneca page 30 Bayer page 31 Boehringer Ingelheim page 32 Eli Lilly (Lilly) page 33 GSK page 34 Janssen page 35 Merck & Co (US) page 36 Novartis page 37 Pfizer page 38 Roche page 39 Sandoz page 40 Sanofi page 41 Teva page 42 Janssen Pharmaceutical Companies of Johnson & Johnson profiles of the 15 companies, according to the respiratory patient groups familiar with these companies, or which have worked with them Each profile contains... company background information Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. = increase in revenue over the previous year or = decrease in revenue. The profiled company s main treatment subject areas (and areas of R&D). A mission statement from the profiled company. how the company has performed at the six indicators of corporate reputation The profiled company s performance at the six indicators of corporate reputation in 2015, according to the respiratory patient groups familiar with the company. The profiled company s performance at the six indicators of corporate reputation, according to the respiratory patient groups that have worked with the company. How the profiled company performed among respiratory patient groups for different countries/regions, compared with the company s global averages for respiratory patient groups in how the company ranks for corporate reputation compared with other companies The profiled company s rankings among respiratory patient groups in 2015 for the six indicators of corporate reputation, compared with 14 other companies. The profiled company s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies. profile of the patient groups familiar with the company Other companies that partner with a significant number of the profiled company s partner patient groups. The countries of the patient groups familiar with the profiled company.

6 Contact details PatientView Registered office: One Fleet Place, London, EC4M 7WS, UK Tel: +44-(0) Registered in England, number: Data protection registration number: Z VAT registration number: GB Copyright 2016 PatientView Ltd. All rights reserved. This booklet is the property of PatientView, and no part may be reproduced without permission, or passed on to any third party without the permission of PatientView.